Exelixis
EXEL
#1697
Rank
C$13.96 B
Marketcap
$48.89
Share price
1.92%
Change (1 day)
53.36%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company